Fig. 2From: Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trendsTime from initiation of treatment to shift (months, mean [IQR]) from VKA to NOACsBack to article page